single dose of CNCT19 Clinical Trials
4 recruitingBiologic
Phase 23Phase 11Early Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.47 enrolled9 locationsNCT05667506
Recruiting
Phase 2
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
Relapsed or Refractory Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.100 enrolled11 locationsNCT04684147
Recruiting
Phase 2
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Juventas Cell Therapy Ltd.60 enrolled17 locationsNCT04586478
Recruiting
Early Phase 1
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
Lupus Erythematosus, Systemic
Juventas Cell Therapy Ltd.24 enrolled1 locationNCT06316791